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Abstract
Background: The world has recently overcome the first influenza pandemic of the 21st century caused by a novel
H1N1 virus (pH1N1) which is a triple reassortant comprising genes derived from avian, human, and swine influenza
viruses and antigenically quite different from seasonal H1N1 strains. Although the case fatality rates have decreased
in many developed countries, the situation is still alarming in many developing countries including India where
considerable numbers of new cases are appearing everyday. There is still a high morbidity and mortality of
susceptible adult as well as young population without having underlying health issues due to the influenza
infection.
Results: To achieve a better understanding of the risk posed by the pH1N1 and to understand its pathogenicity,
we studied the host gene expression response to Indian isolate of pH1N1 infection and compared it with seasonal
H1N1 infection. The response was studied at four different time points (4, 8, 16 and 24 h) post infection (hpi) in
A549 cells using microarray platform. We found that pH1N1 induces immune response earlier than seasonal H1N1
viruses, but at the later stages of infection there is a suppression of host immune responses. The infection with
pH1N1 resulted in considerable decrease in the expression of cytokine and other immune genes namely IL8,
STAT1, B2 M and IL4 compared to seasonal H1N1.
Conclusion: We propose that the inability to induce strong innate immune response could be a reason for the
high transmissibility, pathogenicity and mortality caused by pH1N1 virus.
Background
The pandemic (H1N1) 2009 influenza A virus (pH1N1)
has already killed more than 19,000 people worldwide
since it appeared in April 2009 [1]. Although on 10
th of
August 2010, the Director General of the World Health
Organization (WHO) has announced that the world is
no longer in phase 6 of influenza pandemic alert and we
are now moving into the post-pandemic period, the
virus transmission is still highly active in many parts of
South Asia, West Africa, and Central America [2]. In
Asia, the most active areas of pandemic influenza virus
transmission currently are in parts of India, Bangladesh,
Bhutan, Myanmar Nepal, and Thailand. The virus
(pH1N1) is still a serious threat to children as well as
susceptible young and old population in developing
countries like India.
Till date, there are reports of 2720 deaths from pan-
demic H1N1 influenza virus infection in India which is
approximately 14% of the total world mortality http://
mohfw-h1n1.nic.in/august.html; http://netindian.in/
news/2010/11/15/0008699/6-h1n1-deaths-india-during-
past-week-govt. The pandemic H1N1 virus is antigeni-
cally distinct from seasonal influenza viruses and the
majority of human population lacks immunity against
this virus [3-5]. The pathogenesis and transmission of
the pH1N1 in humans is not completely known and
many studies are underway. Animal studies have shown
that this virus has a higher replicative power than the
seasonal influenza virus [6,7]. Studies on human macro-
phages have shown that pH1N1 is a weak inducer of
cytokine responses as compared to seasonal H1N1
viruses [8]. In addition, pH1N1 replicates efficiently in
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lesions in the lungs than currently circulating seasonal
human H1N1 virus [9,10]. Earlier findings indicate that
pandemic H1N1 are more pathogenic in mammalian
models than seasonal H1N1 influenza viruses
[6-8,11-13]. The pH1N1 isolates tested in mice and fer-
rets, were found to be replicating more efficiently than
currently circulating human H1N1 viruses [6-8].
The respiratory tract is the primary site of infection
for all the mammalian influenza viruses [13,14]. In this
study we have used human lung epithelial cells (A549)
to study the host gene expression responses to infection
with Indian isolate of pH1N1, isolated in August 2009
and compared it with seasonal H1N1 infection in order
to assess the pathogenicity and transmissibility of pan-
demic (2009) H1N1 influenza virus.
Materials and methods
Viruses and cell line
Pandemic Influenza virus A/Jalna/NIV9436/2009
(H1N1) and seasonal human influenza virus A/NIV/
0914864/2009(H1N1) isolated in the influenza division
of the National Institute of Virology, Pune, India were
used for the study. Human lung epithelial (A549) cell
line was used as host and maintained in Dulbecco’s
modified Eagle’s tissue culture medium (Invitrogen Life
Technologies, Carlsbad, CA, USA) containing 10% fetal
calf serum,100 units/ml penicillin, 100 ug/ml streptomy-
c i ni nt i s s u ec u l t u r ef l a s k s( C o r n i n g ,U S A )a t3 7 ° Ci na
CO2 incubator.
Virus infection
A549 cells were infected with pH1N1 and seasonal
influenza viruses at a multiplicity of infection (MOI) of
3 as described earlier [15]. After 1 hour of adsorption
period, the inoculum was removed and the cells were
washed twice with phosphate buffer saline (PBS) and
supplemented with growth media. Four sets of tissue
culture flasks containing monolayer of A549 cells were
infected corresponding to four different time points post
infection for both the viruses. Mock infected cells at
each time point served as controls. Infection of pH1N1
was performed in BSL-2 laboratory following World
Health Organization norm for handling of pandemic
H1N1 viruses.
Microarray Hybridization
Infected cells were harvested at different time points
post infection, total RNA was extracted from the
infected cells at 4, 8, 16 and 24 hpi using Trizol reagent
(Invitrogen Life Technologies, Carlsbad, CA, USA) and
purified using the RNeasy kit (Qiagen, Germany).
Amplification of RNA and indirect labeling of Cy-dye
was done using Amino Allyl MessageAmp II aRNA
amplification kit (Ambion, Austin, TX, USA) following
manufacturer’s instruction. One hundred nanograms of
total RNA from control and infected cells were used for
the experiments. The RNA was reverse transcribed and
amplified according to manufacturer’sp r o t o c o l .T h e
purified amino allyl aRNA was labeled with Cy3 and
Cy5 for control and experimental samples respectively.
Purified samples were lyophilized, resuspended in hybri-
dization buffer (Pronto Universal Hybridization kit,
Corning) and hybridized on human Discover chip
(Arrayit corporation, Sunnyvale, CA, USA). Hybridiza-
tion was carried out in a Hybstation (Genomic
Solutions, Ann Arbor, MI) and the conditions used were
55°C for 6 h, 50°C for 6 h, and 42°C for 6 h. Scanning
was performed at 5-micron resolutions with the Scan
array express (PerkinElmer, Waltham, MI). Grid align-
ment was done by gene annotation files and raw data
were extracted into MS EXCEL [15].
Data Analysis
Microarray data analysis was carried out with GENO-
W I ZM i c r o a r r a yd a t aa n dp a t h w a ya n a l y s i st o o l( O c i -
mum Biosolutions, Hyderabad, India). Replicated values
for genes were merged and median values of the
expression ratios were considered for the dataset. Unde-
tected spots were removed by filtering. Dye bias was
nullified by applying Loess normalization. Log transfor-
mation (log2) was done to stabilize the variation in
dataset and median centering was performed to bring
down data distribution of dataset close to zero. In order
to detect highly expressed genes, fold change analysis
was done. Genes with 1.5 folds up/down-regulation
were considered as differentially expressed at a p-value
<0.05, Student’s t-test. Functional classification of the
genes was performed using gene ontology and pathway
analysis [15].
Quantitative RT-PCR of host genes using SYBR Green I
Microarray gene expression data was validated by quan-
titative RT-PCR as described earlier [15]. The PCR reac-
tion was performed in triplicates using ABI 7300
real-time PCR system (Applied Biosystems, Foster City,
CA, USA) with Quanti Tect SYBR green RT-PCR kit
(Qiagen, Germany). Reaction efficiency was calculated
by using serial 10-fold dilutions of the housekeeping
gene- b-actin and the sample genes. Melting curve ana-
lysis was performed to verify product specificity. All
quantitations (threshold cycle [CT] values) were normal-
ized to that of b-actin to generate ΔCT, and the differ-
ence among the ΔC Tv a l u eo ft h es a m p l ea n dt h a to f
the reference (uninfected sample) was calculated as
-ΔΔCT. The relative level of gene expression was
expressed as 2
-ΔΔCT. Primer sequences for the genes of
interest were obtained from primer bank and also
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The primer sequences used in this study are as follows:
Beta-Actin_F 5’- CATGAAGTGTGACGTGGA-
CATCC-3’; Beta-Actin_R 5’-GCTGATCCACATCTGCT
GGAAGG-3’; TNFRSF1A_F 5’-TTGCATCCTAGCC
CAGCAG-3’; TNFRSF1A_R 5’-CTGACCCTGGAAAG
AAAAGTC-3’; IL8_F 5’-TGCCAAGGAGTGCTAAAG-
3’; IL8_R 5’-CTCCACAACCCTCTGCAC-3’;B2 M (Beta-
2-microglobin)_F 5’-ATGTCTCGCTCCGTGGCCTTA-
3’; B2 M (Beta-2-microglobin)_R 5’-ATCTTGGGCTGT
GACAAAGTC-3’; STAT1_F 5’- CCATCCTTTGGTA
CAACATGC-3’; STAT1_R 5’-TGCACATGGTGGAGT
CAGG-3’; IFNb_F 5’-CAGCAATTTTCAGTGTCA
GAAGC-3’; IFNb_R 5’-TCATCCTGTCCTTGAGG
CAGT-3’.
Western Blot analysis
Total cellular protein from control and infected A549 cells
at different time points post infection were isolated using
RIPA lysis buffer. Equal amount of proteins (10 μg) from
cell extracts were separated by 12.5% SDS-polyacrylamide
gel electrophoresis (12.5% SDS-PAGE) and transferred to
Hybond-C (Amersham Biosciences) membrane with an
electrotransfer apparatus (Cleaver Scientific Ltd) at 10
Volts (100 mA) for 1 h 30 min. Primary and secondary
antibody interaction was performed in phosphate-buffered
saline (pH 7.5). Primary antibodies used were rabbit anti-
STAT1, mouse anti-CASP3 and mouse anti-b-actin anti-
body (Santa Cruz Biotechnology, Inc. Santa Cruz, CA.
USA). The secondary antibodies were mouse anti-rabbit
and goat anti-mouse secondary antibodies (Santa Cruz
Biotechnology, Inc. Santa Cruz, CA. USA) labeled with
Horseradish peroxidase (HRP). The protein bands were
developed with 3, 3’-Diaminobenzidine tetrahydrochloride
(DABT) and Hydrogen peroxide (H2O2) staining.
Results
Host gene expression profile in response to pandemic
(H1N1) 2009 virus infection
The gene expression profile to pH1N1 infection was
studied at 4 different time points post infection in order
to understand the host responses at different stages of
virus infection. Figure 1A shows overall gene expression
p r o f i l ei nr e s p o n s et op H 1 N 1i n f e c t i o n .T h eg e n e s
showing increased expression compared to controls at
all the time points were mainly involved in T-cell activa-
tion and proliferation and enzyme linked protein signal-
ing whereas, genes showing decrease in expression were
mostly involved in regulation of apoptosis and NF-B
mediated signaling (Table 1A).
At the early stages of virus infection i.e. at 4 hpi, we
found up-regulation of immune genes like TNF-a3,
E G R - 1 ,I L 6 R ,v - F O S ,v - J U N .H o w e v e r ,I L 1 3 R A ,I L 3 R A ,
IL4, STAT1, STAT4 were down-regulated at this time
point of infection. At 8 hpi there was further increase in
the expression of EGR-1, IL6R, TNF-a3, v-FOS and
v-JUN genes and up-regulation of other immune respon-
sive genes like IL-8. Surprisingly, we observed more
number of immune genes getting down-regulated at this
stage as compared to 4 hpi. The down-regulation of this
set of immune genes was more prominent at later stages
(16 and 24 hpi) of infection with pandemic H1N1. Genes
involved in intracellular signaling and DNA repair like
Topoisomerase II, MAP2K6 were also found to be down-
regulated at 8 hpi. Higher expression of IL8, TNF-a3,
T N F R - 6 ,C X C R 4 ,E G R - 1 ,v - J U Nw a sf o u n da t1 6h p i .
Gene coding for IL13RA showed continued down-regula-
tion at this stage of infection. Interestingly, at 24 h post
infection there was no further increase in immune
responsive genes but down-regulation of STAT4, TNFR,
IL4R, and TNF6 genes were found.
Host gene expression profile in response to seasonal
H1N1 virus infection
In case of seasonal H1N1 infection there was up-regula-
tion of very few immune responsive genes at the early
stage (4 hpi) of infection. In fact, there was down-regu-
lation of genes involved in innate immune response like
IL2, IL15 and STAT1 at early stages (4 and 8 hpi) of
infection. Figure 1B shows hierarchical clustering of
overall cellular gene expression profile in response to
seasonal H1N1 virus infection in A549 cells. Gene
ontology analysis of differentially expressed genes at all
the time points showed not much differences in the
type and functions of host genes affected by the pH1N1
and seasonal influenza virus infections (Table 1A and
Table 1B). The total number of differentially expressed
genes at different post infection time points during the
two virus infections is given in Table 2.
At 4 hour post infection with seasonal H1N1, genes
encoding for the ribosomal proteins and DNA modify-
ing enzymes were up-regulated and continued to be
up-regulated at all the time points post infection studied
in this experiment. Increased level of the expression of
immune genes was observed from 16 hpi. Cytokines like
CCL5, small inducible cytokine A2, IL8 and other
immune responsive genes like STAT1, IRF1 and B2 M
were found to be up-regulated at this time point post
infection with seasonal influenza virus. At 24 hpi there
was further increase in the expression of immune and
ribosomal genes. There was up-regulation of additional
transcription factors and signaling molecules at 24 hpi.
However, some of the cytokines, signaling genes and
DNA repair genes were selectively down regulated at all
the post infection time points. These genes mainly
included IGF2R, Topoisomerase I and IL13RA1. Genes
involved in cell cycle like Cyclin G1, G2 were down-
regulated at all the time points post infection.
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between pH1N1 and seasonal H1N1 infection
Host gene expression profile was compared at all the
time points between the two virus infections separately.
There were 11, 4, 10 and 20 genes found common
between the two virus infections at 4, 8, 16 and 24 hpi
respectively. Although there was difference in the level
of expression, the expression pattern of the genes was
found to be quite similar among the two virus infec-
tions. However, the expression of some immune genes
like IL4, IL8, B2 M, TNFRF1a and STAT1 was found to
be contrastingly different between the seasonal and pan-
demic influenza virus infection (Figure 2) which was
further confirmed using quantitative real-time PCR
(Figure 3). The expression of genes involved in immune
response, DNA repair and signal transduction were
Figure 1 Hierarchical clustering of differentially expressed genes in A) pandemic influenza H1N1 and B) seasonal influenza virus
infected A549 cells at different post-infection time points. Expression of genes with fold change >+/- 1.5 and p < 0.05 were considered as
differentially expressed. Data presented are averaged gene expression changes for 2 different replicates. Black bar indicate expression pattern of
immune genes in the two virus infected cells.
Table 1 Significantly enriched Gene Ontology terms in response to infection with pandemic H1N1(2009) and seasonal
H1N1 influenza viruses
A. Pandemic H1N1 A. Seasonal H1N1
Term % P-Value Term % P-Value
regulation of cell proliferation 30.2 2.70E-13 regulation of apoptosis 27 1.80E-17
regulation of apoptosis 28.1 2.00E-11 regulation of cell proliferation 20.9 1.60E-10
leukocyte activation 15.6 1.20E-09 positive regulation of apoptosis 14.7 1.50E-09
response to cytokine stimulus 10.4 3.50E-09 regulation of cell cycle 12.9 2.40E-09
regulation of protein kinase activity 15.6 1.00E-07 negative regulation of apoptosis 12.9 7.60E-09
lymphocyte activation and immune response 12.5 1.30E-07 protein amino acid phosphorylation 17.2 2.00E-08
cytokine-mediated signaling pathway 8.3 5.20E-07 lymphocyte activation 8.6 7.20E-07
positive regulation of signal transduction 12.5 6.10E-06 immune system development 9.8 1.00E-06
positive regulation of transcription from RNA polymerase II
promoter
13.5 9.60E-06 transmembrane receptor protein tyrosine kinase
signaling pathway
8 1.50E-05
inflammatory response 11.5 8.40E-05 regulation of DNA replication 4.3 9.20E-05
regulation of I-kappaB kinase/NF-kappaB cascade 7.3 9.90E-05 positive regulation of B cell activation 2.5 6.90E-03
MAPKKK cascade 8.3 2.90E-04 JAK-STAT cascade 2.5 1.10E-02
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(pH1N1 and seasonal H1N1 influenza virus) for better
understanding of the host responses elicited by them.
Analysis revealed that 9 DNA repair genes, 17 immune
related genes and 40 genes involved in signal transduc-
tion processes were common between the two virus
infections (Figure 2 and Figure 4). There was a greater
decrease in expression of interleukins, TNFs and heat
shock genes in response to pH1N1 infection compared
to seasonal H1N1 (Figure 2). There was no significant
change in the expression of signaling genes between the
two virus infections (Figure 4). However, there was sig-
nificant decrease in the expression of tyrosine kinases in
pH1N1 infected A549 cells compared to seasonal H1N1
infected cells.
Validation of Microarray data using Real Time PCR and
Western blot analysis
Expression of selected genes namely STAT1, B2 M,
TNFRSF1A and IL8 known to be involved in immune
response to influenza A virus infection was validated using
Real-time PCR, which correlated with the microarray
results (Figure 3). Expression of IFN-b, an important anti-
viral factor was studied using Real time PCR (Figure 5).
STAT1, which plays a significant role in activation of
innate immune response to viral infection, was further
s t u d i e df o rp r o t e i ne x p r e s s i o nu s i n gW e s t e r nb l o t t i n g
(Figure 6). Expression of apoptotic factor, Caspase 3
(CASP3) was also studied using Western blot analysis and
it was found that the pandemic H1N1 virus infection
resulted in higher expression of CASP3 in later stages of
infection as compared to seasonal H1N1 (Figure 6).
Discussion
Global spread of pandemic (2009) influenza A (H1N1)
virus was found to be much faster as compared to ear-
lier pandemics. Rapid transmission of the pandemic
H1N1 virus, its efficiency to infect hundreds of millions
of people worldwide and its impact in public health dur-
ing the peak pandemic period prompted us to initiate
study on host gene expression profile to pandemic
H1N1 infection in human lung epithelial cells using
microarray platform.
I nt h ep r e s e n ts t u d yw eh a v ec o m p a r e dt h eh o s tg e n e
expression responses to pandemic H1N1 and seasonal
H 1 N 1v i r u si n f e c t i o ni nl u n ge pithelial (A549) cells.
Functional analysis of differentially expressed genes in
both the infections revealed qualitative similarity in the
gene expression profiles i.e. the type of genes affected
were found similar between the two virus infections
(Table 1A and 1B). However, there was quantitative dif-
ference in the number of differentially expressed genes in
pH1N1 and seasonal H1N1 infections. The number of
differentially expressed genes in response to seasonal
H1N1 infection was higher than that of the pH1N1 at all
the time points. This indicates that higher numbers of
host genes were getting influenced by seasonal H1N1
than the pandemic H1N1 virus infection. There was a
difference in the infection stage at which the genes
involved in host immune response were activated during
the pandemic and seasonal influenza virus infections. We
observed up-regulation of immune genes at early stages
of pH1N1 virus infection compared to seasonal H1N1.
However, later stages of infection with pH1N1 were
accompanied by a characteristic impairment of the innate
immune responses (Figure 2 and Figure 3) characterized
by defective cytokine responses as compared to seasonal
H1N1. The high infectivity of pandemic H1N1 in animal
models as observed in other studies [7,8] could be due to
a better subversion of host immune responses by this
virus. Cytokine and interferon genes which are important
components of innate immunity [16] were also found to
be down-regulated at later stages of infection with
pH1N1. Similar decrease in immune response during
pandemic (H1N1) 2009 virus infection has been reported
earlier also [17]. Expression of IFN-b gene, which is an
Table 2 Summary of genes differentially expressed in response to infection with pandemic and seasonal H1N1 viruses
Time-points post
infection
Genes qualifying quality criteria in
replicated experiments
Differentially expressed genes (+/- 1.5
folds, p < 0.05)
Up-regulated
genes
Down-regulated
genes
Seasonal H1N1
4 h 230 60 28 32
8 h 147 44 28 16
16 h 164 63 30 33
24 h 212 102 51 51
Pandemic H1N1
4 h 194 41 8 33
8 h 198 49 14 35
16 h 203 23 13 10
24 h 312 93 28 65
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PCR (Figure 5). IFN-b is the most potent antiviral cyto-
kine and is massively produced during Influenza A virus
infection [18]. Virus should have capability to overcome
antiviral action of interferon during its course of infection
in order to replicate efficiently. We found that both the
viruses have the property of antagonizing INF-b,b u t
pH1N1 infection results in stronger suppression of host
INF-b expression at early stages (4 hpi) as compared to
seasonal H1N1. Also, suppression of INF-b was stronger
at later stages (24 hpi) of pandemic virus infection. These
observations indicate greater replicative ability of
pandemic viruses in the host cells as compared to seaso-
nal H1N1 (Figure 5). An early activation of Caspase 3
(Figure 6) is indicative of an early host response to seaso-
nal H1N1 infection as compared to pH1N1. However, at
the later stages higher level Caspase 3 expression by
pH1N1 infection could be a viral mediated response and
the overall Caspase 3 expression pattern indicates a dif-
ferential ability of the two viruses to induce apoptosis.
Probably pH1N1 inhibit apoptosis in the early stages of
infection and utilizes cellular machinery more efficiently
to get a better replicative ability as compared to seasonal
H1N1 virus infection.
To further validate the differences in the host immune
responses to seasonal H1N1 and pH1N1 virus infection,
we studied the expression of STAT1 protein (Figure 6).
STAT1 protein is an important component of Jak-Stat
pathway which gets activated at later stages of virus infec-
tion. Activation of Jak-Stat pathway results in stimulation
of Interferon regulatory genes leading to heightened
immune responses [16,18]. We observed higher expression
of STAT1 protein in seasonal H1N1 infection at later
stages as compared to pH1N1 (Figure 6). This is indicative
of suppression of STAT1 at later stages of pandemic
H1N1 virus infection, which might decrease the overall
host innate immune response. On the other way, suppres-
sion of STAT1 leads to inhibition of interferon regulatory
genes allowing rapid replication and consequent spread of
pH1N1 compared to seasonal H1N1. NS1 protein of
Figure 2 A comparative analysis of expression profiles of immune responsive genes in response to pandemic H1N1 (2009) and
seasonal H1N1 virus infections.
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H1N1 and pandemic H1N1) in A549 cells were selectively taken for RT-PCR analysis. The expression of these genes was found to be
contrastingly different between the two virus infection in the microarray analysis which correlated with the RT PCR analysis. Error bars indicate
mean+/- standard deviation (SD) for 3 replicates. Expression of b-actin gene was used as internal control.
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seasonal H1N1 virus infections.
Figure 5 Expression of IFN-b gene in cells infected with seasonal and pandemic H1N1 viruses. The RNA isolated at different time points
post infection (4, 8, 16 and 24 hpi) from both the virus infected cells was used to study gene expression using real-time PCR. The expression
values are relative expressions compared to controls. Expression of b-actin gene was used as internal control. Error bars indicate mean+/-
Standard deviation for 3 replicates. A. Expression profile in Real-time PCR experiment. B. Visualization of RT-PCR products on 2% Agarose gel. M:
50 bp Marker; 4C-control at 4 hpi; 4I-infected at 4 hpi; 8C-control at 8 hpi; 8I-infected at 8 hpi; 16C-control at 16 hpi; 16I-infected at 16 hpi; 24C-
control at 24 hpi; 24I-infected at 24 hpi.
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nize host interferon activity to lead virus replication. The
pathogenicity and transmission of influenza A viruses are
likely determined in part by replication efficiency in
human cells, which is the net effect of complex virus-host
interactions. A recent study have shown that the influenza
A virus that circulate in human differ markedly in the abil-
ity of their NS1 protein to block the activation of inter-
feron regulatory gene (IRF3) and interferon beta
transcription [19]. Probably NS1 protein of pH1N1 is
more potent in antagonizing host interferon activity com-
pared to seasonal H1N1 viruses in mammalian cell line
(A549) which facilitates rapid viral replication.
Indian isolates of 2009 pandemic H1N1, although
overall similar to Mexican strain is reported to cause
greater mortality in India on the basis of clinical
records. During the peak pandemic period almost 90%
cases were found positive for pH1N1 in New York City
and other many other regions. However, both seasonal-
H1N1 and pandemic H1N1 were represented in almost
e q u a lp r o p o r t i o ni nI n d i a np o p u l a t i o nd u r i n gt h ep e a k
pandemic period [20]. Although many gaps remain in
understanding how a pandemic influenza virus behaves,
spread and affect the community, in Indian scenario,
along with viral factors other socio-economic and envir-
onmental factors may also be involved in high patho-
genesis of pandemic H1N1 virus.
Conclusion
It is well established that pH1N1 is highly transmissible
as it has rapidly spread to large number of countries
within a very short period of time. We propose that
high transmissibility of pandemic H1N1 virus in the
year 2009-2010 is because of its better subversion of
host immune responses compared to the seasonal influ-
enza viruses. Additionally, lack of earlier immunity to
pH1N1 virus makes it more pathogenic as compared to
seasonal H1N1.
Abbreviations
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